Literature DB >> 34149251

Clinical Application of Time in Range and Other Metrics.

Grazia Aleppo1.   

Abstract

Time in range (TIR) and other continuous glucose monitoring (CGM)-derived metrics have been standardized in international consensus conferences. TIR correlates closely with A1C; a TIR of 70% correlates to an A1C of 6.7-7%. Evidence is emerging on the association of TIR with long-term diabetes complications, and each 10% increase in TIR shows a substantial decrease in risk for long-term complications. Application of TIR to clinical practice can be easily done with a stepped approach to the analysis and interpretation of CGM-derived metrics and the ambulatory glucose profile report. Clinician education and partnership with patients are crucial for successful implementation of TIR and all CGM-derived metrics in clinical practice.
© 2021 by the American Diabetes Association.

Entities:  

Year:  2021        PMID: 34149251      PMCID: PMC8178724          DOI: 10.2337/ds20-0093

Source DB:  PubMed          Journal:  Diabetes Spectr        ISSN: 1040-9165


  38 in total

1.  The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.

Authors:  Robert A Vigersky; Chantal McMahon
Journal:  Diabetes Technol Ther       Date:  2018-12-21       Impact factor: 6.118

2.  The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.

Authors:  Roy W Beck; Crystal G Connor; Deborah M Mullen; David M Wesley; Richard M Bergenstal
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

3.  Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics.

Authors: 
Journal:  Diabetes Care       Date:  2018-06       Impact factor: 19.112

Review 4.  Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology.

Authors:  Rodolfo J Galindo; Grazia Aleppo
Journal:  Diabetes Res Clin Pract       Date:  2020-10-13       Impact factor: 5.602

5.  Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.

Authors:  Viral N Shah; Stephanie N DuBose; Zoey Li; Roy W Beck; Anne L Peters; Ruth S Weinstock; Davida Kruger; Michael Tansey; David Sparling; Stephanie Woerner; Francesco Vendrame; Richard Bergenstal; William V Tamborlane; Sara E Watson; Jennifer Sherr
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 6.  Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice.

Authors:  Mary L Johnson; Thomas W Martens; Amy B Criego; Anders L Carlson; Gregg D Simonson; Richard M Bergenstal
Journal:  Diabetes Technol Ther       Date:  2019-06       Impact factor: 6.118

7.  The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.

Authors:  Roy W Beck; Richard M Bergenstal; Peiyao Cheng; Craig Kollman; Anders L Carlson; Mary L Johnson; David Rodbard
Journal:  J Diabetes Sci Technol       Date:  2019-01-13

8.  Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.

Authors:  Ava S Runge; Lynn Kennedy; Adam S Brown; Abigail E Dove; Brian J Levine; Sophie P Koontz; Varun S Iyengar; Sarah A Odeh; Kelly L Close; Irl B Hirsch; Richard Wood
Journal:  Clin Diabetes       Date:  2018-04

Review 9.  Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange.

Authors:  Gina Agiostratidou; Henry Anhalt; Dana Ball; Lawrence Blonde; Evgenia Gourgari; Karen N Harriman; Aaron J Kowalski; Paul Madden; Alicia H McAuliffe-Fogarty; Molly McElwee-Malloy; Anne Peters; Sripriya Raman; Kent Reifschneider; Karen Rubin; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2017-12       Impact factor: 19.112

10.  Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.

Authors:  Qingyu Guo; Pu Zang; Shaoying Xu; Wenjing Song; Zhen Zhang; Chunyan Liu; Zhanhong Guo; Jing Chen; Bin Lu; Ping Gu; Jiaqing Shao
Journal:  J Diabetes Res       Date:  2020-02-06       Impact factor: 4.011

View more
  1 in total

1.  Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: protocol for a randomised controlled trial.

Authors:  Anders Nikolai Ørsted Schultz; Robin Christensen; Georg Bollig; Kristian Kidholm; F Brandt
Journal:  BMJ Open       Date:  2022-04-27       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.